CMH — Chordate Medical Holding AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK17.08m
- SEK8.62m
- SEK0.98m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.13 | ||
| Price to Tang. Book | 2.52 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 17.49 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -196.01% | ||
| Return on Equity | -223.15% | ||
| Operating Margin | -3029% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 1.16 | 0.62 | 0.88 | 0.11 | 0.98 | n/a | n/a | 0.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Chordate Medical Holding AB (publ) is a medical technology company based in Sweden. The Company develops treatment method through nerve stimulation for chronic nasal congestion. The Company’s headquartered is located in Kista, Sweden.
Directors
- Henrik Rammer CHM (46)
- Anders Weilandt CEO (59)
- Niklas Lindecrantz CFO (52)
- Jan Lindberg VRD (64)
- Petra Libert DSL (47)
- Jan Hermansson OTH (64)
- Tommy Hedberg DRC (65)
- Gunilla Lundmark DRC (57)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 20th, 2014
- Public Since
- March 8th, 2017
- No. of Employees
- 3
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 306,024,605.32
- Address
- Kistagangen 20 B, KISTA, 164 40
- Web
- https://www.chordate.com/
- Phone
- +46 840011586
- Contact
- Anders Weilandt
- Auditors
- PricewaterhouseCoopers AB
Upcoming Events for CMH
Similar to CMH
Acarix AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Aegirbio AB
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Chordate Medical Holding AB (publ) share price?
As of Today at 19:05 UTC, shares in Chordate Medical Holding AB (publ) are trading at SEK0.06. This share price information is delayed by 15 minutes.
How has the Chordate Medical Holding AB (publ) share price performed this year?
Shares in Chordate Medical Holding AB (publ) last closed at SEK0.06 and the price had moved by -84.35% over the past 365 days. In terms of relative price strength the Chordate Medical Holding AB (publ) share price has underperformed the FTSE Global All Cap Index by -85.66% over the past year.
What are the analyst and broker recommendations for Chordate Medical Holding AB (publ)?
There is no consensus recommendation for this security.
What is the Chordate Medical Holding AB (publ) dividend yield?
Chordate Medical Holding AB (publ) does not currently pay a dividend.
Does Chordate Medical Holding AB (publ) pay a dividend?
Chordate Medical Holding AB (publ) does not currently pay a dividend.
When does Chordate Medical Holding AB (publ) next pay dividends?
Chordate Medical Holding AB (publ) does not currently pay a dividend.
How do I buy Chordate Medical Holding AB (publ) shares?
To buy shares in Chordate Medical Holding AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Chordate Medical Holding AB (publ)?
As of the previous close price of SEK0.06, shares in Chordate Medical Holding AB (publ) had a market capitalisation of SEK17.08m.
Where are Chordate Medical Holding AB (publ) shares listed?
Here are the trading details for Chordate Medical Holding AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: CMH
What kind of share is Chordate Medical Holding AB (publ)?
Based on an overall assessment of its quality, value and momentum Chordate Medical Holding AB (publ) is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Chordate Medical Holding AB (publ) share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Chordate Medical Holding AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chordate Medical Holding AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -74.93%.
As of the last closing price of SEK0.06, shares in Chordate Medical Holding AB (publ) were trading -66.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Chordate Medical Holding AB (publ) PE Ratio?
The Chordate Medical Holding AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Chordate Medical Holding AB (publ)?
Chordate Medical Holding AB (publ)'s management team is headed by:
- Henrik Rammer - CHM
- Anders Weilandt - CEO
- Niklas Lindecrantz - CFO
- Jan Lindberg - VRD
- Petra Libert - DSL
- Jan Hermansson - OTH
- Tommy Hedberg - DRC
- Gunilla Lundmark - DRC